Jump Financial’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-82,772
Closed -$2.36M – 2348
2026
Q2
$2.36M Buy
+82,772
New +$1.8M 0.02% 825
2026
Q1
– Sell
-100,956
Closed -$1.9M – 1947
2025
Q4
$1.9M Buy
100,956
+67,849
+205% +$1.14M 0.02% 705
2025
Q3
$481K Buy
+33,107
New +$472K 0.01% 1315
2024
Q4
– Sell
-75,382
Closed -$2.35M – 1683
2024
Q3
$2.35M Buy
75,382
+51,552
+216% +$1.28M 0.05% 452
2024
Q2
$370K Buy
+23,830
New +$288K 0.01% 1282
2023
Q3
– Sell
-117,816
Closed -$1M – 1879
2023
Q2
$1M Sell
117,816
-10,012
-8% -$83.5K 0.04% 678
2023
Q1
$1.17M Buy
127,828
+86,843
+212% +$1.11M 0.05% 537
2022
Q4
$468K Sell
40,985
-9,196
-18% -$136K 0.02% 807
2022
Q3
$854K Sell
50,181
-1,400
-3% -$30K 0.03% 676
2022
Q2
$1.11M Buy
51,581
+43,081
+507% +$1.19M 0.05% 524
2022
Q1
$314K Sell
8,500
-37,100
-81% -$1.45M 0.01% 1046
2021
Q4
$2.07M Buy
+45,600
New +$2.38M 0.13% 192
2021
Q1
– Sell
-17,500
Closed -$1.27M – 974
2020
Q4
$1.27M Buy
+17,500
New +$1.01M 0.22% 108

Other funds holding CDNA

Jump Financial's CDNA Position: Q3 2026 in Review

Jump Financial sold out of CareDx (CDNA) in Q3 2026, closing a stake of 82,772 shares — an estimated $2.36M sold.

Jump Financial first reported a position in CDNA in Q4 2020 and held it in 13 quarters. The position peaked at $2.36M in Q2 2026. 308 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Jump Financial reported no remaining CareDx position as of Q3 2026 after selling out during the quarter.
  • Jump Financial sold 82,772 CareDx shares in Q3 2026, an estimated $2.36M.
  • Jump Financial first reported a position in CareDx in Q4 2020 and held it in 13 quarters.
  • Jump Financial's CareDx position peaked at $2.36M in Q2 2026.
  • 308 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.